DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2021 - 2026)
DiaMedica Therapeutics (DMAC) reported Interest Coverage Ratio of 455.74 for Q1 2026, up 94.4% on a YoY basis from 234.43 in Q1 2025, and up 94.4% quarter-over-quarter from 8144.0 in Q1 2025.
DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 455.74 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 94.4% year-over-year to 455.74; the trailing twelve-month figure through Mar 2026 stood at 1597.17 (up 73.67% YoY), and the FY2025 full-year result was 3439.7, down 3093.6% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 455.74, up from 8144.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.17 in Q4 2022, with the low at 8144.0 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 1780.46 across 5 years, with a median of 302.16 in 2024.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio plunged 2595.28% — and 2026, when it soared 94.4%.
- DiaMedica Therapeutics' Interest Coverage Ratio stood at 0.17 in 2022, then declined by 19.36% to 0.21 in 2023, then tumbled by 144773.55% to 302.16 in 2024, then sank by 2595.28% to 8144.0 in 2025, then jumped by 94.4% to 455.74 in 2026.
- The last three Interest Coverage Ratio figures came in at 455.74 (Q1 2026), 8144.0 (Q1 2025), and 302.16 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -455.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -455.74 |
| Mar 31, 2025 | -8,144.00 |
| Mar 31, 2024 | -302.16 |
| Dec 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.17 |
| Dec 31, 2021 | -0.17 |